 |
市場調查報告書
商品編碼
1550564
胃輕癱治療市場：按藥物類別、按疾病適應症、按類型、按給藥途徑、按分銷管道、按地區Gastroparesis Treatment Market, By Drug Class, By Disease Indication, By Type, By Route of Administration, By Distribution Channel, By Geography |
||||||
預計2024年全球胃輕癱治療市場規模為79.5億美元，預計2031年將達到109.1億美元，2024年至2031年複合年成長率為4.6%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 79.5億美元 |
| 實際資料 | 2019-2023 | 預測期 | 2024-2031 |
| 預測 2024-2031 年複合年成長率： | 4.60% | 2031年價值預測 | 109.1億美元 |
全球胃輕癱治療市場的成長是由糖尿病和特發性胃輕癱盛行率上升所推動的。胃輕癱（排放延遲）是一種慢性疾病，胃需要很長時間才能排空其內容物。胃輕癱患者會出現噁心、嘔吐、腹脹和進食後的飽脹感。目前，胃輕癱尚無治療方法，可用的治療方法主要集中在症狀管理。與開發新藥相關的研發活動的增加可能會推動市場成長。
市場動態：
全球胃輕癱治療市場的成長是由糖尿病人口增加、特發性胃輕癱盛行率上升以及人們和醫生對胃輕癱的認知不斷提高等因素所推動的。然而，患者對口服藥物的依從性差、缺乏有效的治療方法以及藥物治療的副作用可能會阻礙市場的成長。開拓療效較好、副作用較少的新藥可能為市場提供利潤豐厚的成長機會。
本研究的主要特點
該報告對全球胃輕癱治療市場進行了詳細分析，並以2023年為基準年估計了預測期內（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。 。
它還強調了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、績效和策略等參數，對全球胃輕癱治療市場的主要企業進行概況分析。
研究涵蓋的主要企業包括雅培實驗室、美敦力、邁蘭、輝瑞、強生服務、Bausch Health、Antrotrans、Alembic Pharmaceuticals 等。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球胃輕癱治療市場報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球胃輕癱治療市場的各種策略矩陣來促進他們的決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規及趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 監管場景
- 產品發布/核准
- PEST分析
- 波特分析
- 併購場景
第4章全球胃輕癱治療市場，依藥物類別，2019-2031（十億美元）
- 胃腸蠕動促進劑
- 止吐藥
- 質子幫浦抑制劑
- 其他（肉毒桿菌注射等）
第5章全球胃輕癱治療市場，依疾病適應症，2019-2031（十億美元）
- 糖尿病性胃輕癱
- 特發性胃輕癱
- 術後胃輕癱
第6章 2019-2031 年全球胃輕癱治療市場（按類型）（十億美元）
- 非處方藥
- 處方藥
第7章 全球胃輕癱治療市場，依給藥途徑，2019-2031 年（十億美元）
- 口服
- 注射
- 鼻腔
第8章全球胃輕癱治療市場，按分銷管道，2019-2031（十億美元）
- 醫院藥房
- 零售藥房
- 網路藥房
第9章全球胃輕癱治療市場，按地區，2019-2031（十億美元）
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
第10章競爭格局
- Evoke Pharma, Inc.
- Processa Pharmaceuticals, Inc.
- Neurogastrx, Inc.
- Vanda Pharmaceuticals Inc.
- ANI Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- GlaxoSmithKline plc
- Otsuka Holdings Co., Ltd.
- CinDome Pharma, Inc.
- PTC Therapeutics
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Atlantic Healthcare
- Salix Pharmaceuticals
- Rhythm Pharmaceuticals, Inc.
- Ironwood Pharmaceuticals, Inc.
- Medtronic plc
- Bausch Health Companies Inc.
- Sanofi SA
第11章分析師建議
第12章參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
Global gastroparesis treatment market is estimated to be valued at USD 7.95 Bn in 2024 and is expected to reach USD 10.91 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.6% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 7.95 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 4.60% | 2031 Value Projection: | US$ 10.91 Bn |
Global gastroparesis treatment market growth is driven by rising prevalence of diabetes and idiopathic gastroparesis. Gastroparesis, or delayed stomach emptying, is a chronic disorder, in which the stomach takes too long to empty its contents. Patients suffering from gastroparesis experience nausea, vomiting, bloating and fullness after eating. Currently, there is no cure for gastroparesis and the available treatment options focus on managing the symptoms. Rising research and development activities related to new drug development can drive the market growth.
Market Dynamics:
Global gastroparesis treatment market growth is driven by factors such as increasing diabetic population, rising prevalence of idiopathic gastroparesis, growing awareness about gastroparesis among people and physicians. However, poor patient compliance associated with oral medication, non-availability of effective treatment and side effects of drug therapies can hamper the market growth. Development of novel drugs with better efficacy and less side effects can offer lucrative growth opportunities in the market.
Key features of the study:
This report provides in-depth analysis of the global gastroparesis treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global gastroparesis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbott Laboratories, Medtronic, Mylan, Pfizer, Johnson & Johnson Services, Bausch Health, Antrotrans, Alembic Pharmaceuticals
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global gastroparesis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gastroparesis treatment market
Detailed Segmentation-
- Drug Class Insights (Revenue, USD Bn, 2019 - 2031)
- Prokinetic Agents
- Antiemetic Drugs
- Proton Pump Inhibitors
- Others (Botulinum Toxin Injections, etc.)
- Disease Indication Insights (Revenue, USD Bn, 2019 - 2031)
- Diabetes Gastroparesis
- Idiopathic Gastroparesis
- Post-surgical Gastroparesis
- Type Insights (Revenue, USD Bn, 2019 - 2031)
- Over-the-Counter Drugs
- Prescription Drugs
- Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
- Oral
- Injectables
- Nasal
- Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Evoke Pharma, Inc.
- Processa Pharmaceuticals, Inc.
- Neurogastrx, Inc.
- Vanda Pharmaceuticals Inc.
- ANI Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- GlaxoSmithKline plc
- Otsuka Holdings Co., Ltd.
- CinDome Pharma, Inc.
- PTC Therapeutics
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Atlantic Healthcare
- Salix Pharmaceuticals
- Rhythm Pharmaceuticals, Inc.
- Ironwood Pharmaceuticals, Inc.
- Medtronic plc
- Bausch Health Companies Inc.
- Sanofi S.A.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Gastroparesis Treatment Market, By Drug Class
- Global Gastroparesis Treatment Market, By Disease Indication
- Global Gastroparesis Treatment Market, By Type
- Global Gastroparesis Treatment Market, By Route of Administration
- Global Gastroparesis Treatment Market, By Distribution Channel
- Global Gastroparesis Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Gastroparesis Treatment Market, By Drug Class, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Prokinetic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Antiemetic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Proton Pump Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others (Botulinum Toxin Injections, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Gastroparesis Treatment Market, By Disease Indication, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Diabetes Gastroparesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Idiopathic Gastroparesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Post-surgical Gastroparesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Gastroparesis Treatment Market, By Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
- Over-the-Counter Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Prescription Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Gastroparesis Treatment Market, By Route of Administration, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Injectables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Nasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Gastroparesis Treatment Market, By Distribution Channel, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Gastroparesis Treatment Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020- 2031, e (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country/Sub-region, 2019 - 2031, (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Evoke Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Processa Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Neurogastrx, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vanda Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ANI Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Otsuka Holdings Co., Ltd.
- CinDome Pharma, Inc.
- PTC Therapeutics
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Atlantic Healthcare
- Salix Pharmaceuticals
- Rhythm Pharmaceuticals, Inc.
- Ironwood Pharmaceuticals, Inc.
- Medtronic plc
- Bausch Health Companies Inc.
- Sanofi S.A.
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
